FibroGen (NASDAQ:FGEN) Stock Quotes, Forecast and News Summary

Q: What sector and industry does FibroGen (FGEN) operate in?

FibroGen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

FibroGen Stock (NASDAQ: FGEN) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	135.00 / 2.63M
Day Range	- - -
52 Wk Range	0.33 - 3.02
Market Cap	$73.91M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	27
Short Interest	9.59%
Days to Cover	2.53

Recent News

What's Going On With FibroGen Stock Tuesday?

FibroGen Inc (NASDAQ:FGEN) shares are trading higher Tuesday morning after the company said the FDA cleared its Investigational New Drug (IND) of FG-3165. FibroGen also announced a new clinical trial supply agreement with Regeneron.

Adam Eckert

Why HealthEquity Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

Avi Kapoor

FibroGen Stock Is Surging After The Bell: What's Going On?

FibroGen shares are moving higher in Monday's after-hours session after the company announced the FDA cleared its Investigational New Drug (IND) FG-3165. The company also announced a new clinical trial supply agreement with Regeneron.

Adam Eckert

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

1.4

Strong Sell

Strong Buy

Buy

Hold

Sell

Strong Sell

About FibroGen Inc

Sector

Health Care

Industry

Biotechnology

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing nove...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy FibroGen (FGEN) stock?

You can purchase shares of FibroGen (NASDAQ:FGEN) through any online brokerage.

View our list of the best stock brokerages

Who are FibroGen (FGEN) competitors?

Other companies in FibroGen’s space includes: Serina Therapeutics (AMEX:SER), Anixa Biosciences (NASDAQ:ANIX), Connect Biopharma Hldgs (NASDAQ:CNTB), Intensity Therapeutics (NASDAQ:INTS) and Eagle Pharmaceuticals (NASDAQ:EGRX).

What is the target price for FibroGen (FGEN) stock?

There is no analysis for FibroGen.

What is the forecast for FibroGen (FGEN) stock?

FibroGen has a consensus price target of $10.00.

Current stock price for FibroGen (FGEN)?

The stock price for FibroGen (NASDAQ: FGEN) is $0.743 last updated Today at July 3, 2024 at 4:11 AM EDT.

Does FibroGen (FGEN) pay a dividend?

There are no upcoming dividends for FibroGen.

When is FibroGen (NASDAQ:FGEN) reporting earnings?

FibroGen’s Q2 earnings are confirmed for Monday, August 5, 2024.

Is FibroGen (FGEN) going to split?

There is no upcoming split for FibroGen.

What sector and industry does FibroGen (FGEN) operate in?

FibroGen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

FibroGen

FibroGen (FGEN) Forecast